KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29,970,363 | -47.4% | 164,998 | -43.1% | 1.87% | +1.9% |
| Q4 2022 | $56,971,640 | +48.7% | 289,932 | +70.2% | 1.84% | -21.1% |
| Q3 2022 | $38,313,000 | +35.8% | 170,335 | -23.6% | 2.33% | +62.4% |
| Q2 2022 | $28,206,000 | -8.0% | 222,955 | -7.8% | 1.43% | +45.2% |
| Q1 2022 | $30,664,000 | -3.0% | 241,848 | +0.2% | 0.99% | +14.0% |
| Q4 2021 | $31,614,000 | +7.9% | 241,323 | +0.8% | 0.87% | +27.5% |
| Q3 2021 | $29,289,000 | -13.6% | 239,425 | -19.5% | 0.68% | -15.9% |
| Q2 2021 | $33,888,000 | -3.2% | 297,289 | +2.1% | 0.81% | -10.9% |
| Q1 2021 | $35,016,000 | – | 291,239 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |